Am I in Menopause? Symptoms and How to Tell
Menopause is only certain in hindsight: it counts as reached once your period has been gone for 12 months in a row with no other cause. Before that come the transition years, perimenopause, and that is when most symptoms begin. Average age for natural menopause is about 51, shown by the large US cohort study SWAN (Study of Women's Health Across the Nation) [1].
The clinical staging of these transition years is called STRAW+10. If you want to know exactly which stage you are in and how perimenopause and menopause differ, our perimenopause guide goes deep [2]. Here we stay with the practical question: which symptoms belong to it, and how do you recognize them?
The most common lead symptom is vasomotor symptoms, meaning hot flashes and night sweats (VMS for short). Across the whole transition they hit up to about 80 in 100 women; depending on the study and definition the range is roughly 75 to 80 percent [1, 3]. That range is not false precision, it simply depends on which women were surveyed and whether mild flashes were counted too. An analysis from five European countries, for example, found about 50.3 percent of women with VMS overall, because younger and symptom-free women were included.
For German-speaking countries there is a specific, higher number: in a survey of women aged 45 to 60, 71.2 percent reported hot flashes and night sweats, 81 percent reported some menopausal complaint, and 42.7 percent reported bladder problems [4]. So if it feels like nearly every woman around you is suddenly talking about the same thing, statistically you are right.
A common myth: that hot flashes are a matter of a few months. They are not. In SWAN the median total duration of frequent VMS was 7.4 years, and on average they persisted another 4.5 years after the final period [5]. So plan in years rather than weeks. That is no reason to panic, but a good reason to take the complaints seriously and not just sit them out if they are wearing you down.
To sort out your complaints there is a well-validated self-assessment tool developed in Germany: the Menopause Rating Scale (MRS). It covers 11 complaints, each scored from 0 (none) to 4 (very severe), grouped into three domains [6, 7]. Here is how it looks:
| Domain | Complaints (MRS items) |
|---|---|
| Somatic (somato-vegetative) | hot flashes and sweating, heart discomfort, sleep problems, joint and muscle complaints |
| Psychological | depressed mood, irritability, anxiety, physical and mental exhaustion |
| Urogenital | sexual problems, bladder problems, vaginal dryness |
The MRS is a self-check for the conversation with your gynecologist, not a diagnostic stamp. When several of these complaints come together and your cycle turns irregular, perimenopause is the most likely explanation. In the next sections we go through the most common complaints one by one.
Why Am I Gaining Weight in Menopause, and How Do I Lose It Again?
First the most important clarification: menopause does not make the number on the scale jump up by itself. What shifts is fat distribution. Weight rises slowly with aging anyway, but around the transition more fat is laid down at the belly and around the organs (visceral fat), and muscle mass declines [8].
The SWAN data show this cleanly. At the start of the transition the rate at which fat mass is gained roughly doubles, while lean mass (mostly muscle) drops, until about two years after the final period [8]. But weight gain itself shows no separate menopause spike: it tracks with chronological age. Put another way: menopause redistributes the fat, it does not by itself drive the number up [8].
This matters for one reason: visceral fat, the fat around the organs, is more metabolically active and more harmful than the fat directly under the skin. It is linked to insulin resistance and cardiovascular risk. So the fact that your waist changes while the scale barely moves is neither imagined nor a purely cosmetic issue.
This is still good news, because the most effective lever is known and in your hands: resistance training plus enough protein to hold on to muscle mass. The international PROT-AGE consensus paper recommends 1.0 to 1.2 grams of protein per kilogram of body weight a day for older adults, clearly more than the old 0.8 grams, combined with resistance exercise; people who train actively should aim for 1.2 grams per kilogram or more [9]. For a woman weighing 70 kilograms that is about 70 to 84 grams of protein a day, spread across meals, roughly a palm-sized protein portion per meal from sources like quark, eggs, legumes, fish or poultry.
Keeping muscle keeps your resting metabolism up and works against the shift toward belly fat. The reason is simple: muscle tissue burns energy even at rest, and it is exactly this lean mass that is lost during the transition if you do nothing about it. Resistance training here is not an optional extra for sporty women but the most direct counter to what the body does on its own during the transition.
And now the honest question that the internet often gets wrong: does hormone therapy help with weight loss? No. A Cochrane review (22 randomized trials) found no evidence that estrogen or combined hormone therapy changes body weight or prevents menopausal weight gain [10]. Menopausal hormone therapy (MHT, the medical umbrella term for HRT) may shift fat distribution a little more favorably toward less belly fat, but it is not a weight-loss drug and is not prescribed for that. If you are weighing whether MHT makes sense for your symptoms overall, you will find the honest benefit-risk discussion in our HRT guide.
In practice this means: resistance training two to three times a week, a solid protein source at every meal, and patience with the scale. You are working against the shift in body composition, not against a fixed hormone number.
Brain Fog: Why Can I Suddenly Not Concentrate?
If you have started concentrating worse lately, searching for words, or feeling more forgetful: this is common, it belongs to the transition, and it is usually temporary. That is exactly what SWAN shows. In a 4-year analysis of 2,362 women, processing speed and verbal memory declined during perimenopause but did not get worse and recovered after menopause back to the earlier level [11].
Here is the point to take away: brain fog in menopause is not early-onset dementia. It is a dip during the transition that usually rebounds afterward. That framing takes away much of the fear the symptom tends to trigger.
The fog comes in large part from two sources you can influence: poor sleep and hot flashes. Disrupted sleep and night sweats chew up attention and memory consolidation, the overnight process in which your brain stores what it learned. Someone who wakes several times a night from sweating simply has less mental reserve the next day, and that has nothing to do with the brain cells themselves. Treat the sleep and the VMS, and the perceived concentration often improves [11].
Brain fog is therefore partly downstream of sleep and hot flashes, not a standalone brain injury. That also changes where you start: instead of asking whether something is wrong with your memory, it is worth tackling sleep and hot flashes first. How to tackle sleep specifically is below and in the sleep guide. What else helps: regular movement, doing tasks one after another rather than in parallel, and not relying on memory alone for important things but using notes and lists while the transition lasts.
Does hormone therapy help the head? Here you have to be honest, the evidence is mixed, and brain protection is not proven. The WHI Memory Study (WHIMS) found that in women aged 65 and over who started estrogen plus progestin, the risk of probable dementia roughly doubled (hazard ratio 2.05; 95 percent confidence interval 1.21 to 3.48; 45 versus 22 cases per 10,000 person-years; P=0.01) [12]. That is the scenario of a late start far past menopause, and it shows harm rather than protection. It does not prove a cognitive benefit of an early MHT start. The full nuance, timing and target group, is in the HRT guide.
Bottom line: take brain fog seriously, but do not catastrophize it. Repair sleep, treat hot flashes, keep moving, and in most cases the head clears again after the transition.
Joint Pain in Menopause: Is It the Estrogen?
Yes, estrogen probably plays a role. Joint pain (arthralgia) affects more than half of women around menopause, and it appears to become more common with the transition. The leading explanation is the drop in estrogen, which normally has a hand in pain processing, immune cells and cartilage cells [13]. When that protection falls away, knees, fingers and shoulders make themselves heard.
But the honesty behind it matters: so-called menopausal arthralgia is real, yet partly a diagnosis of exclusion. A review with the apt title fact or fiction concludes that the link is real but understudied, and that there is no dedicated treatment for it [13]. So before you blame everything on hormones, other causes should be ruled out: osteoarthritis (joint wear), inflammatory arthritis such as rheumatoid arthritis (which can newly appear at this age), thyroid disease, and vitamin D deficiency [13]. That belongs in a medical conversation, not in self-diagnosis.
A randomized trial shows that estrogen really does act on the joints. In the estrogen-only arm of the Women's Health Initiative (10,739 women without a uterus, conjugated estrogen 0.625 mg a day versus placebo), joint pain occurred less often after one year than with placebo (76.3 versus 79.2 percent, P=0.001), and the effect held through year three [14]. Interestingly, the frequency of swollen joints was slightly higher on estrogen (42.1 versus 39.7 percent, P=0.02), so the picture is not uniformly clear [14]. All of this is real but small, a difference of a few percentage points. Read it as a pointer to the mechanism, not a treatment recommendation, because the decision about hormone therapy is settled in the HRT guide.
A practical note for context: menopausal joint pain often affects several joints at once and is often stiffest in the morning and after rest. That very pattern overlaps with inflammatory arthritis, which is why a medical work-up matters so much. Persistent swelling, redness or warmth over a joint, or morning stiffness lasting well over half an hour, should be checked out rather than chalked up to hormones.
What you can do yourself is well supported and comes first: movement. A combination of resistance training and mobility or endurance keeps joints supple and the muscles that support the joint strong. On top of that, keep an eye on weight and have the contributing causes named above treated. Here, exercise is not a consolation prize but the first line [13, 14].
Sleep Problems and Night Sweats: What Actually Helps?
Sleep problems are among the 11 core complaints of the Menopause Rating Scale, and they are closely tied to nighttime sweating (night sweats) and to trouble falling and staying asleep (insomnia) [6]. Many women wake from a heat surge, others simply lie awake for no obvious reason.
The best-supported first line against insomnia in menopause is not a pill but a short, targeted therapy: cognitive behavioral therapy for insomnia (CBT-I). It teaches you to get your sleep pressure and sleep-wake rhythm back in order rather than just numbing the symptoms. In a MsFLASH trial of 106 peri- and postmenopausal women with hot flashes, telephone-delivered CBT-I produced clear, clinically meaningful and lasting improvements in sleep quality and insomnia severity versus a menopause-education control, and it also reduced how much the hot flashes interfered with daily life [15].
The key point: CBT-I works on the insomnia itself, even when the hot flashes are still there [15]. So you do not have to wait for the VMS to go away, and you do not necessarily need a sleeping pill either. That matters especially in menopause, because many women assume that without treating the hot flashes nothing can be done about sleep anyway. The evidence says the opposite.
Sleep hygiene (fixed times, a cool dark bedroom, a screen break in the evening, cutting caffeine and alcohol in the late afternoon and evening) and treating the night sweats are sensible add-ons, but they do not replace CBT-I. Against night sweats specifically, a cool bedroom, breathable bedding and light sleepwear that absorbs sweat all help in practice. None of that fixes the cause, but it makes the nights more bearable while you work on the insomnia itself.
Good news for German-speaking countries: CBT-I is accessible, not a luxury. Behavioral therapy is in principle covered by statutory health insurance as guideline psychotherapy, and for insomnia there are additional digital programs, some as an app on prescription (DiGA) covered by insurance (as of 2026, when in doubt clarify with your doctor or insurer). Waiting times for a therapy slot do vary, though.
How sleep architecture works and how to improve deep sleep on purpose is covered in our sleep guide. For menopause the rule is: take the insomnia seriously as its own problem, start with CBT-I, and treat the night sweats in parallel.
Skin Aging and Collagen Loss: What's Happening to My Skin?
If your skin seems to get thinner, drier and more wrinkled faster after menopause, that is not just in your head. The classic, often-cited number: women lose roughly 30 percent of their skin collagen in the first 5 years or so after menopause, then about 1 to 2 percent a year [16]. An honest qualifier on that: the exact figure of about 30 percent in 5 years is the widely cited distillation of Brincat's work from the 1980s, not a single measured sentence from one paper. The original paper reports a decline of 1 to 2 percent per year [16, 17]. So treat the 30 percent figure as an established rule of thumb, not a value measured to the decimal.
That estrogen deficiency is behind the collagen loss is backed by data. Brincat and colleagues showed that skin collagen and skin thickness decline with years since menopause, not with chronological age alone [17]. A study by Affinito and colleagues found a clear drop in skin collagen types I and III in women after menopause compared with women before it (P<0.01), what the authors called an estrogen-related phenomenon [18]. And in a small study with estradiol gel (16 women, 12 months), the collagen content of abdominal skin rose significantly (P<0.001) [19]. That explains the mechanism, but it is not a skincare prescription: estrogen on or for the skin is off-label, meaning not approved for that purpose, and not a standard recommendation.
What you can actually do is, fortunately, well supported and available without hormones. The best evidence among creams belongs to retinoids (vitamin A acid, tretinoin). A systematic review of 7 randomized trials found that tretinoin reliably improves fine lines, uneven pigmentation, sallowness and age spots, with first effects from about one month and benefit out to 24 months, because it stimulates new collagen and inhibits collagen-degrading enzymes [20]. In Germany tretinoin is prescription-only and not reimbursed for pure anti-aging use (self-pay); over-the-counter retinol cosmetics work more weakly.
The highest-yield lever, though, is simple and cheap: UV protection. Photoaging from UV radiation is a larger and more controllable driver of visible skin aging than the hormonal share, which is why daily broad-spectrum sun protection is the non-negotiable baseline. Put another way: the hormonal share of skin aging is real but you can only influence it so much, while the UV share is large and entirely in your hands. So if you want to do something for your skin in menopause, you start not with hormones but with sunscreen and a retinoid. The full skin protocol with retinoids, sunscreen and actives is in the skin-aging guide.
And finally the question that comes up across all the sections: what can you do about the symptoms overall? For every area there is a lever without hormones (resistance training and protein, repairing sleep, movement for the joints, retinoids and sunscreen for the skin). And there is the option of hormone therapy, which works most strongly against hot flashes. Whether MHT is right for you, with all the honest pros and cons, the reinterpretation of the WHI study and the timing window (before 60 and within 10 years of menopause), is best settled with the detailed discussion in the HRT guide and with your gynecologist.
Frequently Asked Questions
When does menopause start, and how do I notice it?
Menopause itself only counts in hindsight, once the period has been gone for 12 months in a row; the average age is about 51 (SWAN) [1]. But symptoms usually begin earlier, in perimenopause, typically with an irregular cycle, hot flashes, sleep problems and mood swings. The Menopause Rating Scale, with its 11 complaints, helps to place it [6].
How long do hot flashes in menopause last?
Longer than most people think. In SWAN the median total duration of frequent hot flashes and night sweats was 7.4 years, and on average they persisted another 4.5 years after the final period [5]. The idea that it is over after a few months does not hold for most women.
Do you inevitably gain weight in menopause?
No, menopause does not drive the number on the scale up on its own. What shifts is fat distribution: more fat at the belly and around the organs, less muscle mass (SWAN) [8]. The most effective counter-lever is resistance training plus enough protein; the PROT-AGE paper recommends 1.0 to 1.2 g per kg of body weight a day [9].
Does hormone therapy help with weight loss in menopause?
No. A Cochrane review (22 trials) found no evidence that estrogen or combined hormone therapy changes body weight or prevents weight gain [10]. MHT may make fat distribution slightly more favorable, but it is not a weight-loss drug and is not prescribed for that. The full benefit-risk discussion is in the [HRT guide](/en/guide/hormonersatztherapie-hrt-trt).
Is brain fog in menopause a sign of dementia?
As a rule, no. In SWAN, processing speed and verbal memory declined during perimenopause but recovered afterward to the earlier level [11]. The fog is strongly tied to poor sleep and hot flashes; treating those often improves concentration too.
What helps most against sleep problems in menopause?
The proven first line is cognitive behavioral therapy for insomnia (CBT-I). In a MsFLASH trial of 106 women it produced clear, lasting improvements in sleep and insomnia versus plain education, and it works even when the hot flashes persist [15]. In Germany it is accessible as guideline psychotherapy and partly as an app on prescription (DiGA).
Does joint pain in menopause really come from estrogen?
Probably in part. More than half of women around menopause have joint pain, and the estrogen drop is the leading explanation [13]. In the estrogen arm of the WHI, joint pain occurred less often after one year (76.3 versus 79.2 percent) [14]. Important: osteoarthritis, arthritis, thyroid disease and vitamin D deficiency should be ruled out medically first [13].
What helps against skin aging in menopause?
The highest-yield lever is daily broad-spectrum sun protection, because UV radiation is the larger and more controllable driver of visible skin aging. Among creams, retinoids (tretinoin) have the best evidence: 7 randomized trials showed better wrinkles, pigmentation and sallowness from about one month [20]. Estrogen for the skin, by contrast, is off-label and not a standard recommendation [19]. More in the [skin-aging guide](/en/guide/hautalterung-stoppen).
Sources
- El Khoudary SR, Greendale G, Crawford SL, Avis NE, Brooks MM, Thurston RC, Karvonen-Gutierrez C, Waetjen LE, Matthews K. (2019). The menopause transition and women's health at midlife: a progress report from the Study of Women's Health Across the Nation (SWAN). Menopausedoi:10.1097/GME.0000000000001424
- Harlow SD, Gass M, Hall JE, Lobo R, Maki P, Rebar RW, Sherman S, Sluss PM, de Villiers TJ. (2012). Executive summary of the Stages of Reproductive Aging Workshop +10: addressing the unfinished agenda of staging reproductive aging. Menopausedoi:10.1097/gme.0b013e31824d8f40
- Thurston RC, Joffe H. (2011). Vasomotor symptoms and menopause: findings from the Study of Women's Health Across the Nation. Obstetrics and Gynecology Clinics of North Americadoi:10.1016/j.ogc.2011.05.001
- Buhling KJ, Daniels BV, Studnitz FSGV, Eulenburg C, Mueck AO. (2014). The use of complementary and alternative medicine by women transitioning through menopause in Germany: results of a survey of women aged 45-60 years. Complementary Therapies in Medicinedoi:10.1016/j.ctim.2013.12.004
- Avis NE, Crawford SL, Greendale G, Bromberger JT, Everson-Rose SA, Gold EB, Hess R, Joffe H, Kravitz HM, Tepper PG, Thurston RC. (2015). Duration of menopausal vasomotor symptoms over the menopause transition. JAMA Internal Medicinedoi:10.1001/jamainternmed.2014.8063
- Heinemann K, Ruebig A, Potthoff P, Schneider HPG, Strelow F, Heinemann LAJ, Do MT. (2004). The Menopause Rating Scale (MRS) scale: a methodological review. Health and Quality of Life Outcomesdoi:10.1186/1477-7525-2-45
- Heinemann LAJ, DoMinh T, Strelow F, Gerbsch S, Schnitker J, Schneider HPG. (2004). The Menopause Rating Scale (MRS) as outcome measure for hormone treatment? A validation study. Health and Quality of Life Outcomesdoi:10.1186/1477-7525-2-67
- Greendale GA, Sternfeld B, Huang MH, Han W, Karvonen-Gutierrez C, Ruppert K, Cauley JA, Finkelstein JS, Jiang SF, Karlamangla AS. (2019). Changes in body composition and weight during the menopause transition. JCI Insightdoi:10.1172/jci.insight.124865
- Bauer J, Biolo G, Cederholm T, Cesari M, Cruz-Jentoft AJ, Morley JE, Phillips S, Sieber C, Stehle P, Teta D, Visvanathan R, Volpi E, Boirie Y. (2013). Evidence-based recommendations for optimal dietary protein intake in older people: a position paper from the PROT-AGE Study Group. Journal of the American Medical Directors Associationdoi:10.1016/j.jamda.2013.05.021
- Norman RJ, Flight IHK, Rees MCP. (2000). Oestrogen and progestogen hormone replacement therapy for peri-menopausal and post-menopausal women: weight and body fat distribution. Cochrane Database of Systematic Reviewsdoi:10.1002/14651858.CD001018
- Greendale GA, Huang MH, Wight RG, Seeman T, Luetters C, Avis NE, Johnston J, Karlamangla AS. (2009). Effects of the menopause transition and hormone use on cognitive performance in midlife women. Neurologydoi:10.1212/WNL.0b013e3181a71193
- Shumaker SA, Legault C, Rapp SR, Thal L, Wallace RB, Ockene JK, Hendrix SL, Jones BN, Assaf AR, Jackson RD, Kotchen JM, Wassertheil-Smoller S, Wactawski-Wende J. (2003). Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study (WHIMS). JAMAdoi:10.1001/jama.289.20.2651
- Magliano M. (2010). Menopausal arthralgia: fact or fiction. Maturitasdoi:10.1016/j.maturitas.2010.04.009
- Chlebowski RT, Cirillo DJ, Eaton CB, Stefanick ML, Pettinger M, Carbone LD, Johnson KC, Simon MS, Woods NF, Wactawski-Wende J. (2013). Estrogen alone and joint symptoms in the Women's Health Initiative randomized trial. Menopausedoi:10.1097/GME.0b013e31828392c4
- McCurry SM, Guthrie KA, Morin CM, Woods NF, Landis CA, Ensrud KE, Larson JC, Joffe H, Cohen LS, Hunt JR, Newton KM, Otte JL, Reed SD, Sternfeld B, Sung J, LaCroix AZ. (2016). Telephone-Based Cognitive Behavioral Therapy for Insomnia in Perimenopausal and Postmenopausal Women With Vasomotor Symptoms: A MsFLASH Randomized Clinical Trial. JAMA Internal Medicinedoi:10.1001/jamainternmed.2016.1795
- Brincat M, Kabalan S, Studd JW, Moniz CF, de Trafford J, Montgomery J. (1987). A study of the decrease of skin collagen content, skin thickness, and bone mass in the postmenopausal woman. Obstetrics and Gynecology
- Brincat M, Moniz CF, Studd JWW, Darby A, Magos A, Emburey G, Versi E. (1985). Long-term effects of the menopause and sex hormones on skin thickness. British Journal of Obstetrics and Gynaecologydoi:10.1111/j.1471-0528.1985.tb01091.x
- Affinito P, Palomba S, Sorrentino C, Di Carlo C, Bifulco G, Arienzo MP, Nappi C. (1999). Effects of postmenopausal hypoestrogenism on skin collagen. Maturitasdoi:10.1016/S0378-5122(99)00077-8
- Brincat M, Versi E, O'Dowd T, Moniz CF, Magos A, Kabalan S, Studd JWW. (1987). Skin collagen changes in post-menopausal women receiving oestradiol gel. Maturitasdoi:10.1016/0378-5122(87)90045-4
- Sitohang IBS, Makes WI, Sandora N, Suryanegara J. (2022). Topical tretinoin for treating photoaging: a systematic review of randomized controlled trials. International Journal of Women's Dermatologydoi:10.1097/JW9.0000000000000003
Talk About Menopause, With Women Who Get It
Become part of Longevity Cities. Trade notes on strength training, sleep, MHT conversations and finding the right gynecologist, with women in the same life window.
Join the CommunityRelated Guides
Sleep and Longevity
Good sleep is one of the strongest things you can do for healthy aging. Here is why.
Longevity for Women
Women's healthspan, hormonal aging, and evidence-based strategies
Perimenopause: The Decade That Shapes Your Healthspan
STRAW+10 staging, what your symptoms really mean, what HRT guidelines say in 2026, and which check-ups are worth your time.
HRT & TRT: Protocols and Honest Evidence
What the WHI re-analysis actually flipped. What the T-Trials and TRAVERSE 2023 showed. And how HRT and TRT are really prescribed in DACH.
Stop Skin Aging
Sugar, collagen, sun protection and menopause. What keeps skin visibly younger, based on what the dermatology evidence actually shows.
The information provided here is for educational purposes only. Longevity China does not provide medical advice, diagnosis, or treatment. Always seek the advice of qualified healthcare providers with questions regarding medical conditions.
